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Genetic polymorphismThe aim of this study was to provide a comprehensive analysis of the worldwide genetic polymorphism of
ms4760 alleles of the pfnhe-1 gene and to discuss their usefulness as molecular marker of quinine resis-
tance (QNR). A new numbering of ms4760 allele, classiﬁcation grouping ms4760 alleles according to the
number of DNNND and DDNHNDNHNND repeat motifs in blocks II and V was also proposed.
A total of 1508 ms4760 sequences from isolates, culture-adapted parasites or reference strains from
various geographical regions were retrieved from GenBank (last update on 15th June 2012) or from pub-
lications and were used for genetic analyses. The association of different alleles of pfnhe-1with resistance
to quinoline antimalarial drugs showed marked geographic disparities.
The validity and reliability of candidate polymorphisms in pfnhe-1 gene as molecular markers of QNR
appeared restricted to endemic areas from South Asia or possibly East African countries and needs to be
conﬁrmed.
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Quinine (QN), a natural compound found in Cinchona bark, has
been used for centuries in malaria endemic regions (Baird, 2005). It
is currently recommended for treating severe malaria cases, malar-
ia in pregnant women or as second-line therapy in combination
with antibiotic for uncomplicated malaria (World Health Organiza-
tion, 2010a). Though clinical failures have been reported in Asia
and South America in the 1960s and later on, although more rarely
in Africa, resistance to QN (QNR) remains particularly punctual and
rare (Chongsuphajaisiddhi et al., 1983; Pukrittayakamee et al.,
1994, 2000; de Vries et al., 2000; McGready et al., 2000, 2005; Rah-
man et al., 2001; Adam et al., 2005; Adegnika et al., 2005; Achan
et al., 2009; World Health Organization, 2010a,b).
QN, a quinoline derivative, is a monoprotic weak base that accu-
mulates within the low pH environment of the parasite digestive
vacuole of Plasmodium falciparum. QN presumably acts by interfer-
ence with the detoxiﬁcation of heme produced during hemoglobin
degradation by P. falciparum asexual blood stages, leading to toxic
degradation by-products (Hawley et al., 1998). However, the mech-
anism of QNR is not well known. Several reports have documented
associations between in vitro susceptibility to QN with other struc-
turally related drugs such as amino-4-quinolines (chloroquine,
amodiaquine) or aryl-amino-alcohol (meﬂoquine, halofantrine),
suggesting that a common genetic determinant may affect the
parasite response to these antimalarials (Simon et al., 1986; War-
same et al., 1991; Basco and Le Bras, 1992; Brasseur et al., 1992).
Particularly, QNR has been associated with mutations in the P. fal-
ciparum multidrug resistance 1 gene (pfmdr-1) and the P. falciparum
chloroquine resistance transporter gene (pfcrt) (Wongsrichanalai
et al., 2002; Valderramos and Fidock, 2006). More recently, other
genetic polymorphisms, such as mutations in the P. falciparumChromosome 13                           
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Fig. 1. Schematic representation of pfnhe-1 gene (PF13_0019) on chromosome 13 and
variations (msR1, ms3580 and ms4760).multi-resistance protein 1 gene (pfmrp-1) have been suggested (Mu
et al., 2003), but not conﬁrmed (Anderson et al., 2005). However,
PfMRP knock-out parasite lines displayed increase susceptibly to
several antimalarial drugs, including chloroquine, QN and artemis-
inin derivatives (Raj et al., 2009). The degree of implication or link-
age of the three genes in QNR remains uncertain, probably because
additional genes are involved. In 2004, by using quantitative trait
loci (QTL) analysis on the genetic cross of the HB3 and Dd2 clones,
Ferdig et al. (2004) identiﬁed genes associated with QN reduced
susceptibility (Ferdig et al., 2004), namely pfmdr-1 on chromosome
5, pfcrt on chromosome 7 and pfnhe-1 (P. falciparum Na+/H+
exchanger-1) on chromosome 13. To test for an association of QN
response with this latter gene, pfnhe-1 was resequenced from the
HB3 and Dd2 parents and the identiﬁed coding frame polymor-
phisms were surveyed in 71 P. falciparum culture-adapted isolates
and reference lines from South-East Asia, Africa and Central and
South America. Sequences of pfnhe-1 showedmultiple and complex
variations. Three point polymorphisms at three separate codons
(790 gtc/ttc, 894 aat/aaa, 950 ggg/gtg) and microsatellite variations
in three different repeat sequences (msR1, ms3580 and ms4760)
were observed (Fig. 1). Moreover, there was a signiﬁcant
association between variations in ms4760 and in vitro QN response.
One of the eight ms4760 proﬁles, ms4760-1, was relatively fre-
quent in lines with reduced susceptibility to QN (i.e. higher IC90),
but it was also present in fully susceptible parasites. More interest-
ingly, the authors reported that presence of more than 2 DNNND
repeat motifs in block II was associated with higher in vitro IC90
for QN compared with presence of only one repeat (Ferdig et al.,
2004).
The physiological role of PfNHE-1 is still debated. In all living
organisms, the fundamental homeostatic mechanisms are ubiqui-
tous and vital. These physiological processeswhich regulate cellular3.2 Mb
5’
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exchange of cations implying several transporters like the family of
Na+/H+ exchangers (NHEs) (Pouyssegur et al., 1984; Putney and Bar-
ber, 2003). Investigations performed in 1993 by the group of Gins-
burg have shown that the major role of P. falciparum Na+/H+
exchanger was to increase the cytosolic pH (pHcyt) and to compen-
sate acidosis caused by anaerobic glycolysis (Bosia et al., 1993).
PfNHE-1, a 226 kDa proteinwith 12 predicted trans-membrane seg-
ments (Gardner et al., 2002; Ferdig et al., 2004), is supposed by some
authors to reside in the parasite’s plasma membrane (Bosia et al.,
1993;Bennett et al., 2007) but othersunderlined that the subcellular
localization of this protein is not established (Nkrumah et al., 2009).
Saliba and Kirk (1999) demonstrated that P. falciparummaintains its
pHcyt byusingmainly aV-typeH1-ATPase,which serves as themajor
route for the efﬂux of H+ ions (Saliba and Kirk, 1999). Later, in 2007,
Bennett et al. (2007) showed that high level ofQNRwas correlated to
an increased PfNHE-1 activity which determines pHcyt. They also
demonstrated that antimalarial drug resistances were related to
modiﬁcations of ion transport across plasma (pHcyt) and digestive
vacuole (pHDV) membranes and concluded that pairwise interac-
tions of genetic determinants located on chromosome 13 and chro-
mosome 9 affecting pHcyt and PfNHE-1 were involved in QNR
(Bennett et al., 2007). However, using the protocols of Bennett
et al., Spillman et al. (2008) showed that the Na+-dependent efﬂux
of H+ from parasites acidiﬁed using nigericin/BSA was attributable
to Na+/H+ exchange via residual nigericin remaining in the parasite
plasma membrane, rather than to endogenous transporter activity
(Spillman et al., 2008). Likewise, Nkrumah et al. (2009) were unable
to reproduce the Na+/H+-exchanger activity observed by Bennett
et al., (Nkrumah et al., 2009) but they provided evidences that
PfNHE-1 expression levels inﬂuenced QN sensitivity in concert with
additional parasite genetic factors such as PfCRT, PfMDR1 and possi-
bly additional yet unidentiﬁed parasite proteins. However, varia-
tions in PfNHE-1 expression levels did not impact on pHcyt.
Since the seminal work by Ferdig et al. (2004), several studies
have been conducted in different countries to evaluate the pfnhe-
1 polymorphisms and its association with in vitro QN susceptibility
(Vinayak et al., 2007; Henry et al., 2009; Andriantsoanirina et al.,
2010, 2012; Baliraine et al., 2010; Briolant et al., 2010, 2011; Meng
et al., 2010; Okombo et al., 2010; Pelleau et al., 2011; Sinou et al.,
2011). Conﬂicting data have been reported, likely due to the differ-
ent geographical origin of parasites (implying different genetic
backgrounds), the type of parasites used (fresh isolates, culture-
adapted strains and reference lines) and the method used to assess
in vitro QN susceptibility (Okombo et al., 2011; Pelleau et al., 2011).
Thus, the implication of PfNHE-1 polymorphisms in QNR remains
to be studied in detail.
The aim of this study was to provide a comprehensive analysis
of the worldwide genetic polymorphism of ms4760 alleles of the
pfnhe-1 gene and to discuss their usefulness as molecular marker
of quinine resistance.2. Plasmodium falciparum Na+/H+ exchanger (Pfnhe-1) allele
polymorphism
Following the initial work of Ferdig et al. (2004) on genetic
polymorphism of ms4760 within the pfnhe-1 gene, a total of
1508 ms4760 sequences from isolates, culture-adapted parasites
or reference strains from various geographical regions were re-
trieved from GenBank (last update on 15th June 2012) or from
publications (Table 1) and were used for genetic analyses. A new
numbering of ms4760 allele according to the chronological order
of the data of the publication was conducted. Classiﬁcation
grouping ms4760 alleles according to the number of DNNND andDDNHNDNHNND repeat motifs in blocks II and V was also
performed.
Ms4760 sequences were aligned and compared using the Clus-
tal Wmultiple alignment algorithm in BioEdit Sequence Alignment
editor (Hall, 1999). Genetic diversity was assessed by Nei’s unbi-
ased expected heterozygosity (He) from haploid data and calcu-
lated as He = [n/(n  1)][1  pi] (n = the number of isolates
sampled; pi = the frequency of the ith allele) (Nei, 1978). Popula-
tion genetic differentiation was measured using Wright’s F statis-
tics (Wright, 1965); population genetic parameters were
computed with FSTAT software, v2.9.4 (Goudet, 1995).
The Mann-Whitney U test or Kruskal–Wallis method were used
for non-parametric comparisons, and Student’s t test or one-way
analysis of variance for parametric comparisons. For categorical
variables, Chi-squared or Fisher’s exact tests were used to assess
signiﬁcant differences in proportions.
All reported P-values are two-sided and were considered statis-
tically signiﬁcant if less than 0.05.
2.1. Global genetic polymorphism of ms4760 in pfnhe-1 gene
Amongst the 1508 studied sequences, 101 different ms4760 al-
leles were observed. Ms4760 alleles were renumbered according to
the chronology of the publication of the studies (ranging from
ms4760-1 to ms4760-101) and are presented in Table 2. Alignment
of sequences of blocks I–VI in ms4760 are displayed in Fig. 2.
2.1.1. Geographical distribution of ms4760 alleles: between continents
According to the location of the sample collection, 39 ms4760
alleles were observed in Asia (n = 398), 74 in Africa (n = 1070), 5
in South America (n = 17), 2 in Papua New Guinea (n = 5) and one
in Haiti (n = 1). Five alleles were globally distributed (ms4760-1,
ms4760-3 ms4760-5, ms4760-6, ms4760-7) while others were
exclusively found in Asia and in Africa (n = 24, ms4760-2,
ms4760-8, ms4760-9, ms4760-12, ms4760-14, ms4760-15 and
ms4760-18 to ms4760-35) or only in Asia (n = 10, ms4760-4,
ms4760-10, ms4760-11, ms4760-13, ms4760-16, ms4760-17 and
ms4760-98 to ms4760-101) or only in Africa (n = 45, from
ms4760-36 to ms4760-64, from ms4760-66 to ms4760-173 &
ms4760-90 to ms4760-97). Seventeen alleles have unknown ori-
gins (ms4760-65 & ms4760-74 to ms4760-89). Data are presented
in Table 2 and Fig. 3.
2.1.2. Geographical distribution of ms4760 alleles: within continents
and between regions
Amongst the 39 alleles found in Asia, 16 (41%) were shared be-
tween South East Asia (Thailand, Cambodia, Vietnam, Malaysia and
Myanmar/China border) and Central Asia (India), whereas 23 were
speciﬁc to South East Asia. In Africa, the 74 observed alleles were
distributed as follows: three were shared by all regions (West Afri-
ca, East Africa, Central Africa, South Africa, Indian Ocean Islands),
seven were present in all regions except South Africa, ﬁve alleles
were shared by West Africa, East Africa and Central Africa, four
by East Africa, Central Africa and Indian Ocean Islands and 27 by
East Africa and Central Africa. Thirteen alleles were found only in
Central Africa and ﬁfteen in Indian Ocean Islands only. Among
the ﬁve alleles described in South America, only two were shared
by Western countries (Honduras, Colombia, Ecuador and Peru)
and Eastern country (Brazil). Two were speciﬁc from Western
countries and one from Eastern countries (Table 2 and Fig. 3).
2.2. ms4760 proﬁles: geographical distribution and prevalence
According to the number of repeats in block II (DNNND) and
block V (DDNHNDNHNND) which have been associated with mod-
ulation of in vitro QNR (Henry et al., 2009; Andriantsoanirina et al.,
Table 1
Summarized ﬁndings of the studies describing relationships between polymorphisms in pfnhe-1, pfcrt, pfmdr-1 and pfmrp genes and in vitro susceptibility to quinine.
(continued on next page)
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Table 2
Classiﬁcation of pfnhe-1 sequences in 101 different alleles according to the geographical location of the isolates.
Continent
Central East
THA KHM VNM MYS CHN/MMR IND MRT SEN GMB MLI GNB SLE LBR CIV GHA TGO BEN BFA NER SDN KEN UGA DJI CAF TCD COG COD ZAF MOZ COM MDG HND COL ECU PER BRA PNG HTI ?
8 4 81 1 60 244 398 1 5 12 21 2 2 1 5 4 1 1 4 4 6 32 241 1 3 1 76 3 2 1 255 386 1070 1 1 1 5 8 17 5 1 23
ms4760-1 YES
ms4760-2 YES
ms4760-3 YES
ms4760-4
ms4760-5 YES
ms4760-6 YES
ms4760-7 YES
ms4760-8 YES
ms4760-9 YES
ms4760-10
ms4760-11
ms4760-12
ms4760-13
ms4760-14
ms4760-15
ms4760-16
ms4760-17
ms4760-18
ms4760-19
ms4760-20
ms4760-21
ms4760-22
ms4760-23
ms4760-24
ms4760-25
ms4760-26
ms4760-27
ms4760-28
ms4760-29
ms4760-30
ms4760-31
ms4760-32
ms4760-33
ms4760-34
ms4760-35
ms4760-36
ms4760-37
ms4760-38
ms4760-39
ms4760-40
ms4760-41
ms4760-42
ms4760-43
ms4760-44
ms4760-45
ms4760-46
ms4760-47
ms4760-48
ms4760-49
ms4760-50
OTHER
Region South East
Total
West Africa East Africa Central Africa West
Total
Country
ASIA AFRICA SOUTH AMERICA
No. of isolates
m
s4
76
0 
ha
pl
ot
yp
es
South Africa Indian Ocean Islands
Total
ms4760-51
ms4760-52
ms4760-53
ms4760-54
ms4760-55
ms4760-56
ms4760-57
ms4760-58
ms4760-59
ms4760-60
ms4760-61
ms4760-62
ms4760-63
ms4760-64
ms4760-65
ms4760-66
ms4760-67
ms4760-68
ms4760-69
ms4760-70
ms4760-71
ms4760-72
ms4760-73
ms4760-74
ms4760-75
ms4760-76
ms4760-77
ms4760-78
ms4760-79
ms4760-80
ms4760-81
ms4760-82
ms4760-83
ms4760-84
ms4760-85
ms4760-86
ms4760-87
ms4760-88
ms4760-89
ms4760-90
ms4760-91
ms4760-92
ms4760-93
ms4760-94
ms4760-95
ms4760-96
ms4760-97
ms4760-98
ms4760-99
ms4760-100
ms4760-101
m
s4
76
0 
ha
pl
ot
yp
es
Countries are designed by the 3-letters codes used by the United Nations: THA, Thailand; KHM, Cambodia; VNM, Vietnam; MYS, Malaysia; CHN, China; MMR, Myanmar; IND,
India; MRT, Mauritania; SEN, Senegal; GMB, Gambia; MLI, Mali; GNB, Guinea-Bissau; SLE, Sierra Leone; LBR, Liberia; CIV, Côte d’Ivoire; GHA, Ghana; TGO, Togo; BEN, Benin;
BFA, Burkina Faso, NER, Niger; SDN, Soudan; KEN, Kenya; UGA, Uganda; DJI, Djibouti; CAF, Central African Republic; TCD, Chad; COG, Congo; COD, Congo, the Republic
Democratic of the; ZAF, South Africa; MOZ, Mozambique; COM, Comoros; MDG, Madagascar; HND, Honduras; COL, Colombia; ECU, Ecuador; PER, Peru; BRA, Brazil; PNG,
Papua New Guinea; HTI, Haiti. Grey box means ‘‘ms-4760 haplotype never detected’’ and black box means ‘‘ms-4760 haplotype detected at least once’’.
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Fig. 2. Alignment of the 101 ms4760 protein sequences found in Genbank and in publications.
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ms4760-A to ms4760-O) presented in Table 3. The number of re-
peats in block II (DNNND) varied from 0 (ms-4760-A) to 6
(ms4760-O) while the number of repeats in block V
(DDNHNDNHNND) from 1 (ms4760-B, ms4760-E, ms4760-I,
ms4760-L, ms4760-O) to 4 (ms4760-H). Sixty-six percent of ms-
4760 alleles were grouped in 4 proﬁles: ms-4760-C [(DNNND)1;
(DDNHNDNHNND)2] (23%), ms-4760-F [(DNNND)2; (DDNHND
NHNND)2] (15%), ms-4760-E [(DNNND)2; (DDNHNDNHNND)1]
(14%) and ms-4760-I [(DNNND)3; (DDNHNDNHNND)1] (14%). Four
proﬁles were globally distributed (ms-4760-C, ms-4760-E, ms-
4760-F and ms-4760-L), ﬁve were observed in both Asia and Africa
(ms-4760-A, ms-4760-B, ms-4760-D, ms-4760-H and ms-4760-J),
two were only found in Asia (ms-4760-I, ms-4760-N) and four only
in Africa (ms-4760-G, ms-4760-K, ms-4760-M and ms-4760-O)
(Fig. 3).The mean number of DNNND repeats was signiﬁcantly higher in
Asia (2.30, SD = 0.78) compared to Africa (2.06, SD = 0.90,
P < 0.001). Inversely, the number of DDNHNDNHNND repeats
was signiﬁcantly lower in Asia (1.34, SD = 0.51) compared to Africa
(1.72, SD = 0.54, P < 0.001). Consequently, the mean ratio of
DNNND/DDNHNDNHNND repeats was signiﬁcantly higher in Asia
(2.03 ± 0.98 vs. 1.46 ± 1.05, P < 0.001).
The prevalence of the pfnhe-1 ms4760 proﬁles according to the
geographical location of the isolates (continent & country) signiﬁ-
cantly differed between continents (P < 0.0001, Table 4 and Fig. 4).
In both continents (Asia & Africa), 11 proﬁles had a low prevalence
(<10%). Three proﬁles were predominant in Africa (ms-4760-F,
32.9%; ms-4760-C, 21.3% and ms-4760-I, 15.5%), and four in Asia
(ms-4760-I, 37.1%; ms-4760-E, 28.1%; ms-4760-C, 14.3% and ms-
4760-F, 10.9%). Interestingly, the prevalence of the ms-4760-C (1
DNNND repeat) decreased from Central Africa (38%) to East Africa
Fig. 3. Geographical distribution of the pfnhe-1 ms4760 proﬁle between and with continents. Numbers in boxes indicate shared ms4760 proﬁles between continents (blue
and grey boxes) and regions (black, green, red, purple and light blue boxes). For each region, numbers of ms4760 proﬁles are split into shared proﬁles (ﬁrst number) and local
proﬁles (second number) (i.e., Madagascar: 14 shared proﬁles and 15 local proﬁles). (For interpretation of the references to colour in this ﬁgure legend, the reader is referred
to the web version of this article.)
Table 3
Phne-1 ms4760 proﬁle groups according to the number of repeat in block II (DNNND) and block V (DDNHNDNHNND) and the geographical location of the isolates.
For each proﬁle (A to O) and continent (Asia, Africa and South America), white box means ‘‘ms-4760 proﬁle never detected’’ and black box means ‘‘ms-4760 proﬁle detected at
least once’’.
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(6%) whereas the prevalence of the ms-4760-I (3 DNNND repeats)
increased along the same west to east axis (7%, 14%, 17%, 23% and
61%).2.3. Genetic diversity and genetic differentiation between parasite
populations
Genetic diversity, assessed by Nei’s unbiased expected hetero-
zygosity (He) was signiﬁcantly higher in Africa (Congo = 0.7649,
Uganda = 0.7975, Kenya = 0.6582), Indian Ocean (Madagas-
car = 0.8053, Comoros Islands = 0.7946) or India (0.6807) com-
pared to China/Myanmar (0.6807, P = 0.04) or Vietnam (0.4981,
P < 0.0001) (Table 4).
The degree of genetic differentiationof thems4760proﬁleswith-
in parasite populations, estimated by Fst values, indicated a large
divergence between Asian populations and African populations(Table 5). The highest differences were observed between popula-
tions fromVietnam or China/Myanmar and populations fromKenya
(Fst = 0.319 and 0.183), Congo (Fst = 0.291 and 0.176), Uganda
(Fst = 0.219 and 0.121), Madagascar (Fst = 0.202 and 0.111), Como-
ros Islands (Fst = 0.171 and 0.083) and India (Fst = 0.171 and
0.069). On the other hand, populations from Africa (Congo, Uganda,
KenyaandMadagascar) showedvery lowdivergenceorwere similar
(Fst from0.0001 to 0.076) and population from Indiawas intermedi-
ate (Fst from 0.070 to 0.163).3. Discussion
The biostatistical analyses performed in this study showed a
large global genetic polymorphism of ms4760 in pfnhe-1 gene.
The African continent displayed the highest number of different al-
leles, followed by Asia and South America. While a few alleles were
shared by three continents, others appeared restricted to Asia and/
Table 4
Prevalence and expected heterozygosity of the pfnhe-1 ms4760 groups according to the geographical location of the isolates (continent & country)
ms4760 proﬁles (%) Prevalence by Continent/Country Total
Africa Asia
Congo Uganda Kenya Madagascar Comoros Islands India China/Myanmar Vietnam
n = 74 n = 172 n = 29 n = 386 n = 251 n = 244 n = 60 n = 79
ms4760-A 1.3 0.0 0.0 2.0 1.5 0.0 0.0 1.3 1.1
ms4760-B 4.1 1.7 7.1 4.4 1.1 0.0 1.6 0.0 2.2
ms4760-C 38.3 22.6 14.2 24.1 11.9 19.2 4.9 6.3 19.2
ms4760-D 5.4 1.1 0.0 2.3 3.5 2.8 0.0 0.0 2.3
ms4760-E 9.5 6.3 3.5 9.8 6.3 36.0 19.7 10.1 13.9
ms4760-F 26.0 33.7 53.5 31.1 34.2 10.2 14.7 10.1 26.3
ms4760-G 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1
ms4760-H 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1
ms4760-I 6.8 13.9 14.2 14.0 21.5 23.2 50.8 69.6 21.9
ms4760-J 8.2 11.0 7.1 8.5 5.1 6.5 3.3 0.0 7.0
ms4760-K 0.0 5.2 0.0 0.0 0.0 0.0 0.0 0.0 0.7
ms4760-L 0.0 2.3 0.0 2.3 14.3 1.6 4.9 2.6 4.5
ms4760-M 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1
ms4760-N 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1
ms4760-O 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1
He 0.765 0.797 0.658 0.805 0.794 0.766 0.680 0.493
He: expected heterozygosity.
Fig. 4. Prevalence of the pfnhe-1 ms4760 proﬁle groups according to the geographical location of the isolates (continent and country). Phne-1 ms4760 proﬁle groups are
described in Table 3 (according to the number of repeat in block II, DNNND and block V, DDNHNDNHNND).
Table 5
Degree of genetic differentiation of the ms4760 proﬁle groups within parasite populations (African and Asian countries), estimated by pairwise population genetic distances (FST).
Uganda Kenya Madagascar Comoros Islands India China/Myanmar Vietnam
Congo 0.01739 0.07610 0.01025 0.06382 0.08763 0.17689 0.29186
Uganda 0.01959 0.00011 0.01911 0.08776 0.12179 0.21948
Kenya 0.02770 0.02876 0.16355 0.18367 0.31962
Madagascar 0.02089 0.07075 0.11195 0.20280
Comoros Islands 0.09344 0.08370 0.17157
India 0.06970 0.17199
China/Myanmar 0.02694
16 D. Ménard et al. / International Journal for Parasitology: Drugs and Drug Resistance 3 (2013) 8–19or Africa. Similarly, within continents, some alleles were shared
between various regions while others appeared restricted to spe-
ciﬁc areas as Central Africa or Indian Ocean. The geographical dis-
tribution and prevalence of ms4760 proﬁles, deﬁned by variations
in the number of repeats in block II and V, differed also signiﬁ-
cantly between continents. Interestingly, the mean ratio of
DNNND/DDNHNDNHNND repeats, proposed by some authors as
associated with in vitro QNR, was signiﬁcantly higher in Asia thanin Africa. The predominant ms4760 proﬁles in Africa were the
same that in Asia, except for the ms-4760-E which was predomi-
nant only in Asia. Some data suggested a geographical diffusion
of some alleles. The prevalence of a particular proﬁle, the ms-
4760-C (1 DNNND repeat), decreased from Central Africa to East
Africa, Indian Ocean, Central Asia and South East Asia while the
prevalence of another ‘‘opposite’’ proﬁle, the ms-4760-I (3 DNNND
repeats), increased along the same west to east axis. Genetic anal-
D. Ménard et al. / International Journal for Parasitology: Drugs and Drug Resistance 3 (2013) 8–19 17ysis using expected heterozygosity He showed a higher genetic
diversity in parasites from Africa (including Indian Ocean Islands)
than in those from Asia. In addition, Fst values indicated a large
divergence between Asian and African populations. These data
showed that the Asian and African populations were clearly
differentiated.
Several studies have described the relationships between poly-
morphisms in pfnhe-1 and in vitro susceptibility to quinine (Ta-
ble 1). Some of these studies have also considered the association
of in vitro susceptibility to quinine with polymorphisms in pfcrt,
pfmdr-1 and pfmrp genes, with conﬂicting results for pfcrt and
pfmrp, and no association (except in one study) with SNPs poly-
morphisms of pfmdr-1 (Table 1).
Following the inaugural study of Ferdig et al. (2004), Henry
et al. (2009) investigated a series of 23 culture-adapted isolates
or reference strains. The relationship between the number of
DNNND repeats and the inhibitory concentration 50% values
(IC50) to QN was conﬁrmed and an increased number of the
DDNHNDNHNND repeat motif was associated with decreased
IC50s to QN. A limitation of these studies was that the in vitro QN
susceptibility and polymorphisms determinations were performed
on culture-adapted cloned isolates or reference strains, which
could lead to biased results due to accumulated mutations selected
by in vitro conditions or to selection of speciﬁc alleles during the
culture. Indeed, a recent study showed an association between
pfnhe-1 polymorphism and in vitro QN response on cultured
adapted isolates but not in ﬁeld isolates (Pelleau et al., 2011).
An increased number of DNNND repeats was positively associ-
ated with in vitro QNR in six studies (Ferdig et al., 2004; Henry
et al., 2009; Meng et al., 2010; Okombo et al., 2010; Pelleau
et al., 2011; Sinou et al., 2011) (Table 1). All these studies used cul-
ture-adapted parasites, except study from Sinou et al. (2011). It is
worth noting that Ferdig et al. (2004) used IC90s rather than IC50s in
the other studies (Ferdig et al., 2004). Parasites having 2 or more
repeats had higher IC90s than parasites having 1 repeat (P < 0.05
for Asia and South America lines). Okombo et al. (2010) observed
this association only for parasites from Kenya having 2 repeats
compared to 1 repeat (P < 0.05) (Okombo et al., 2010). Meng
et al. (2010) reported a strong positive association in a series of
60 adapted isolates from the China–Myanmar border (Meng
et al., 2010). Sinou et al. (2011) also reported a positive association
in a series of 51 clinical fresh isolates from Vietnam: isolates with
two or more DNNNDmotifs were less susceptible to QN than those
harbouring zero or one DNNND repeats (Sinou et al., 2011). Discor-
dant results were reported in a Thai study by Poyomtip et al.
(2012) who did not observe an association between the number
of DNNND repeats and in vitro QNR in a series of 81 culture-
adapted isolates obtained from the Thai–Myanmar border and
the Thai–Cambodia border (Poyomtip et al., 2012).
Pradines and colleagues (2009–2011) published 3 studies of
pfnhe-1 polymorphisms (Henry et al., 2009; Briolant et al., 2010,
2011). In the ﬁrst one, Henry et al., 2009 including 23 reference
strains or culture-adapted isolates of various geographic origin,
found a positive association between the number of DNNND re-
peats and IC50s (Henry et al., 2009). In another study Briolant
et al. (2010, 2011) including 23 reference strains or culture adapted
isolates of similar geographic origin did not found any association
(Briolant et al., 2010). Lastly, in a series of 74 clinical isolates from
Republic of Congo, Briolant et al. (2011) did not found an associa-
tion either (Briolant et al., 2011). Two other studies including
respectively 83 and 172 clinical isolates from African countries
did not ﬁnd any association between an increased number of re-
peats in DNNND and in vitro QNR (Andriantsoanirina et al., 2010;
Baliraine et al., 2010). The studies conducted in Asian areas re-
ported an overrepresentation of the ms4760-7 allele, harboured
by 49.2% and 68.3% of isolates in China–Myanmar border and Viet-nam, respectively (Meng et al., 2010; Sinou et al., 2011). In the
study by Meng et al. (2010), ms4760-7 isolates were among those
having the lowest in vitro susceptibility to QN but other ms4760-7
isolates of that series displayed perfect susceptibility (Meng et al.,
2010). The ms4760-7 allele was also overrepresented in the study
by Henry et al. (2009) including 4 Asian isolates with high IC50s,
ranging from 599 to 1310 nM (Henry et al., 2009). The presence
of the ms4760-7 allele was not rare in other areas, in particular
in African countries (Ferdig et al., 2004; Andriantsoanirina et al.,
2010, 2012; Okombo et al., 2010; Briolant et al., 2011) but without
obvious association with QNR, many isolates harbouring this allele
showing full in vitro susceptibility. Thus, further studies are needed
to conﬁrm whether the ms4760-7 allele is necessary for the emer-
gence QN resistance and can be used in monitoring the QNR spread
in South East Asia.
The number of DDNHNDNHNND repeat motif was associated
with reduced in vitro susceptibility to QN (P < 0.01) in one study
of 83 clinical isolates obtained in African countries (Andriantsoani-
rina et al., 2010). Conversely, an increased number of
DDNHNDNHNND repeats was associated with higher in vitro sus-
ceptibility to QN in studies of isolates from the China–Myanmar
border (Meng et al., 2010) or Vietnam (Sinou et al., 2011). The same
association was observed in one study (Henry et al., 2009) but not
conﬁrmed in 2 subsequent studies by the same team (Briolant
et al., 2010, 2011). Three other studies did not ﬁnd this association
either (Baliraine et al., 2010; Okombo et al., 2010; Poyomtip et al.,
2012).
The usefulness of PfNHE-1 polymorphisms as marker of in vitro
QNR may be inferred from some publications. In parasites from
Asian areas, the number of DNNND repeats has been positively
associated with in vitro QNR in culture-adapted isolates from the
China–Myanmar border (Meng et al., 2010) and in isolates from
Vietnam (Sinou et al., 2011) but not in culture-adapted isolates
from the Thai–Myanmar border and the Thai–Cambodia border
(Poyomtip et al., 2012). In parasites from Africa, the existing data
show no evidence of association of the number of DNNND repeats
and QN susceptibility, excluding its use as a molecular marker of
QNR (Andriantsoanirina et al., 2010; Baliraine et al., 2010; Briolant
et al., 2010, 2011). This may change in the future and the situation
could be particular in Kenya (Okombo et al., 2010) as resistance
genotypes originating from the South-East Asia may have reached
this country as it was the case in the past for chloroquine and antif-
olates resistant P. falciparum.
The number of DDNHNDNHNND repeats does not seem corre-
lated with in vitro QNR or contributing to QNR in Asian areas, so
it does not appear as an interesting marker. Choudhary and Shar-
ma, 2009 studied the polymorphisms in ﬂanking microsatellites
of the pfnhe-1 gene in 108 Indian isolates (Choudhary and Sharma,
2009). They observed an expected heterozygosity of 10 ﬂanking
microsatellites in the vicinity of ±40 kb of pfnhe-1 gene comparable
to any other neutral loci. Thus, no selective sweep or valley of re-
duced variation around ±40 kb of this gene was observed, indicat-
ing that there was no strong selection pressure on the pfnhe-1
gene. In addition, these authors did not ﬁnd an association be-
tween DNNND repeat polymorphisms and microsatellite alleles.
The association of PfNHE-1 polymorphism and clinical resis-
tance remains to be evaluated. Currently, only 2 cases of clinical
failures have been reported. Pradines and colleagues (2011) stud-
ied a QN treatment failure in a traveller from Senegal, and observed
the association of two repeats of DNNND with a reduced in vitro
susceptibility (IC50 = 829 nM) (Pradines et al., 2011). The second
case, a QN treatment failure in a traveller from French Guiana,
did not show this association as the ms4760 microsatellite showed
1 repeat of DNNND and 2 repeats of DDNHNDNHNND, though the
isolate had a reduced susceptibility to QN (IC50 = 1019 nM) (Bert-
aux et al., 2011).
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with clinical failures and/or in vitro susceptibility constitutes a piv-
otal step in the development of tools for the surveillance of emer-
gence and spreading of P. falciparum resistant strains. Such
associations must be veriﬁed on numerous isolates originating
from various geographical areas and supported by molecular stud-
ies to speciﬁcally assess the involvement of the candidate genes in
drug resistance. Recent genetic and physiological studies rein-
forced the conclusion that QNR is a complex trait requiring multi-
ple actors (Nkrumah et al., 2009). Several transporters have been
identiﬁed as determinants of resistance to quinoline antimalarial
drugs. The available data on molecular surveys of potential con-
tributors to QN resistance do not allow to propose a simple molec-
ular typing methodology of global application. It is possibly a
consequence of the multigene nature of the QNR trait, which in-
volves multiple gene interactions. Such gene interactions depend
on the alleles at play in each genetic background and likely show
substantial geographic variations. In particular pfcrt and pfmdr1
known to contribute to QN susceptibility have different alleles in
different geographic settings (Wellems et al., 2009). For example,
CQR P. falciparum strains have originated from at least six different
geographic locations spread across Southeast Asia, Latin America
and the Paciﬁc region (Wootton et al., 2002; Wellems et al.,
2009). African CQR strains have their origins in a single foundation
event, a strain apparently imported from Southeast Asia. In the
case of QN (and of most other antimalarial drugs), the drug pres-
sure that selected for resistance varied considerably with respect
to intensity and time in the different geographic areas. As a result,
the association of different alleles of transporters with resistance to
quinoline antimalarial drugs may show geographic disparities.
Likewise, the ampliﬁcation of pfmdr1, associated with in vitro resis-
tance to QN, meﬂoquine, and halofantrine is frequent in Asia (Price
et al., 2004) but rare in the African continent. Analogous processes
may have occurred for pfnhe-1. However, the absence of selective
sweep in 108 Indian P. falciparum isolates and the lack of associa-
tion of microsatellite markers with DNNND repeats, possibly indi-
cates that there is no strong selection pressure on the pfnhe-1 gene
(Choudhary and Sharma, 2009). Studies summarized in this paper
do not exclude a potential role for PfNHE-1 in QNR in a strain-
dependent manner.
In this context, the validity and reliability of candidate polymor-
phisms in pfnhe-1 gene as molecular markers of QNR appears re-
stricted to endemic areas from South Asia or possibly East
African countries and needs to be conﬁrmed.Funding
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